Communiqués Iconovo AB

Actions

ICO

SE0010868943

Equipement, fournitures et distribution médicale

Temps Différé Nasdaq Stockholm 15:47:03 02/10/2026			Varia. 5j.	Varia. 1 janv.
1,250 ^SEK	-1,19%		+3,31%	+9,65%

20/08	Iconovo AB (publ) publie ses résultats pour le deuxième trimestre et le premier semestre clos le 30 juin 2026	CI
22/06	Iconovo AB (publ.) et Lonza Group AG signent un accord de collaboration stratégique	CI

Communiqués

24/08	Iconovo: Still waiting for commercial proof – Q2 review	AQ
03/07	Iconovo AB (publ) reintroduces liquidity provider agreement with Pareto Securities AB	AQ
29/06	Iconovo terminates liquidity provider agreement	AQ
22/06	Iconovo and Lonza sign Strategic Collaboration Agreement	AQ
24/04	Iconovo: Limited progress – Q1 review	AQ
14/04	Anders Månsson is appointed CEO	AQ
17/03	Iconovo publishes outcome of exercise of warrants series TO 1	AQ
10/03	Iconovo’s rights issue is registered – conversion of BTA into shares	AQ
02/03	Iconovo announces final outcome in the rights issue	AQ
27/02	Iconovo publishes preliminary outcome of rights issue and announces recalculation of warrants series TO 1	AQ
24/02	Iconovo and Lonza signs LOI regarding strategic collaboration	AQ
16/02	Iconovo: Still needs proof – Q4 review	AQ
13/02	Iconovo - Q4 2025 - Intervju	AQ
13/02	The subscription period in Iconovo's rights issue begins today	AQ
12/02	Iconovo publishes information document regarding rights issue of shares	AQ
15/01	Iconovo has initiated a new feasibility study for ICOone® Nasal in collaboration with multinational company	AQ
13/01	EPO declares intention to approve ICOpre® patent application	AQ
22/12	Nomination Committee appointed at Iconovo AB	AQ
16/12	Iconovo announces that the terms and conditions for allotment of shares in directed issue are met	AQ
26/11	Iconovo: Raises capital	AQ
25/11	Iconovo carries out a directed issue of shares of approx. SEK 25 million and a rights issue of shares of approx. SEK 24.6 million, which is covered to 100% by subscription undertakings and guarantee commitments	AQ
31/10/25	Iconovo: New interim CEO appointed	AQ
31/10/25	Iconovo appoints new CEO	AQ
27/10/25	Iconovo (Q3 Review) - An uneventful quarter with solid cost-cutting	AQ
24/10/25	Iconovo: Costs down, focus sharpened – Q3 review	AQ